SARS-CoV-2 CRISPR Screen Analysis: Why Is Clinical Presentation so Variable from Asymptomatic to Death? Can SARS-CoV-2 Therapeutics Be Developed Against Host Targets, and What Is the Role of HMGB1 in Infection?

September 17, 2020

0 Comments
Login to view comments. Click here to Login